共 16 条
[2]
Corrigendum: The Bright Future of Unconventional σ/π‐Hole Interactions[J] . Antonio Bauzá,Tiddo J. Mooibroek,Antonio Frontera.ChemPhysChem . 2015 (15)
[3]
Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases[J] . Fabrizia Bonacina,Andrea Baragetti,Alberico Luigi Catapano,Giuseppe Danilo Norata,Austin Meng Guo.Mediators of Inflammation . 2013
[4]
Increased myocardial prevalence of C-reactive protein in human coronary heart disease: direct effects on microvessel density and endothelial cell survival[J] . Mandar S. Joshi,Liyue Tong,Angela C. Cook,Brandon L. Schanbacher,Hong Huang,Bing Han,Leona W. Ayers,John Anthony Bauer.Cardiovascular Pathology . 2012 (5)
[5]
Circulating Lipoprotein-associated Phospholipase A2 in High-grade Carotid Stenosis: A New Biomarker for Predicting Unstable Plaque[J] . G. Sarlon-Bartoli,A. Boudes,C. Buffat,M.A. Bartoli,M.D. Piercecchi-Marti,E. Sarlon,L. Arnaud,Y. Bennis,B. Thevenin,C. Squarcioni,F. Nicoli,F. Dignat-George,F. Sabatier,P.E. Magnan.European Journal of Vascular & Endovascular Surgery . 2011 (2)
[6]
PENTRAXIN 3 AND C-REACTIVE PROTEIN IN SEVERE MENINGOCOCCAL DISEASE
[J].
SHOCK,
2009, 31 (01)
:28-32
[7]
C‐reactive protein and coronary heart disease: a critical review[J] . J. P.Casas,T.Shah,A. D.Hingorani,J.Danesh,M. B.Pepys.Journal of Internal Medicine . 2008 (4)
[9]
Long pentraxin 3: A marker of inflammation in untreated psoriatic patients[J] . Valentina Bevelacqua,Massimo Libra,Maria Mazzarino,Pietro Gangemi,Giuseppina Nicotra,Salvatore Curatolo,Daniela Massimino,Antonio Plumari,Paola Merito,Guido Valente,Franca Stivala,Stefano La Greca,Grazia Malaponte.International Journal of Molecular Medicine . 2006 (3)
[10]
Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections[J] . Albert T.A.Mairuhu,GiuseppePeri,Tatty E.Setiati,C. ErikHack,PenelopieKoraka,AugustinusSoemantri,Albert D.M.E.Osterhaus,Dees P.M.Brandjes,Jos W.M.van der Meer,AlbertoMantovani,Eric C.M.van Gorp.J. Med. Virol. . 2005 (4)